Redon J, Miralles A, Pascual J M, Baldó E, Robles R G, Carmena R
Hypertension Clinic, Internal Medicine and Endocrinology, University of Valencia, Spain.
J Hypertens. 1997 Jan;15(1):79-86. doi: 10.1097/00004872-199715010-00008.
To analyze the relationship between insulinemia and urinary albumin excretion in a group of nonobese, young adult hypertensive patients, who had never been treated with antihypertensive drugs.
Forty-nine patients who fulfilled the inclusion criteria were included. Twenty-four-hour ambulatory blood pressure monitorings, urinary albumin excretion (UAE) measurements, and an oral glucose-tolerance test measuring glucose and insulin, were performed, and left ventricular mass was measured by echocardiography. Hypertensive patients were classified as normoalbuminuric when their UAE was < 30 mg/24 h (40 patients; mean UAE 13.4 +/- 7.0 mg/24 h), and as microalbuminuric when their UAE was 30-300 mg/24 h (nine patients; mean UAE 90.5 +/- 86.6 mg/24 h).
In comparison with that of the normoalbuminuric group, the fasting plasma glucose concentration for the microalbuminuric group was only slightly higher (100 +/- 9 versus 95 +/- 8 mg/dl, NS). In contrast, the fasting insulin concentration in the microalbuminuric group was significantly higher than that observed in the normoalbuminuric group (25.2 +/- 6.7 versus 16.6 +/- 5.2 microU/ml, P<0.0001). During the oral glucose-tolerance test, the area under the curve (AUC) for glucose (317 +/- 41 versus 253 +/- 53 mg/dl x 2/h, P<0.001) and the AUC for insulin (253 +/- 171 versus 124 +/- 43 microU/ml x 2/h, P<0.001) were significantly higher in the microalbuminuric group than were those AUC observed in the normoalbuminuric group. After adjustments for age, sex, body mass index and average 24 h ambulatory mean blood pressure were made, the fasting insulin level was associated independently with an increase in UAE in a multiple regression model with base 10 logarithm of the UAE as the dependent variable. Variations in fasting insulin level alone accounted for 33% of the UAE variance. In contrast, the 24 h ambulatory mean blood pressure, rather than the insulin level, was the strongest predictor of the left ventricular mass index.
Mild hypertensive patients with microalbuminuria were hyperinsulinemic in the absence of obesity, and their insulin level was the main determinant of microalbuminuria in these patients. Microalbuminuria in essential hypertension seems to identify patients with a cluster of cardiovascular risk factors and a bad risk profile. Thus, assessment of microalbuminuria may be useful in the stratification of risk in essential hypertension.
分析一组从未接受过降压药物治疗的非肥胖年轻成年高血压患者的胰岛素血症与尿白蛋白排泄之间的关系。
纳入49例符合纳入标准的患者。进行24小时动态血压监测、尿白蛋白排泄(UAE)测量以及口服葡萄糖耐量试验以测量血糖和胰岛素,并通过超声心动图测量左心室质量。当UAE<30mg/24h时,高血压患者被分类为正常白蛋白尿(40例患者;平均UAE 13.4±7.0mg/24h),当UAE为30 - 300mg/24h时,被分类为微量白蛋白尿(9例患者;平均UAE 90.5±86.6mg/24h)。
与正常白蛋白尿组相比,微量白蛋白尿组的空腹血糖浓度仅略高(100±9对95±8mg/dl,无显著性差异)。相比之下,微量白蛋白尿组的空腹胰岛素浓度显著高于正常白蛋白尿组(25.2±6.7对16.6±5.2μU/ml,P<0.0001)。在口服葡萄糖耐量试验期间,微量白蛋白尿组的葡萄糖曲线下面积(AUC)(317±41对253±53mg/dl×2/h,P<0.001)和胰岛素AUC(253±171对124±43μU/ml×2/h,P<0.001)显著高于正常白蛋白尿组观察到的AUC。在对年龄、性别、体重指数和平均24小时动态平均血压进行调整后,在以UAE的常用对数为因变量的多元回归模型中,空腹胰岛素水平与UAE的增加独立相关。仅空腹胰岛素水平的变化就占UAE变化的33%。相比之下,24小时动态平均血压而非胰岛素水平是左心室质量指数的最强预测因子。
轻度高血压合并微量白蛋白尿的患者在无肥胖的情况下存在高胰岛素血症,且其胰岛素水平是这些患者微量白蛋白尿的主要决定因素。原发性高血压中的微量白蛋白尿似乎可识别出具有一系列心血管危险因素和不良风险特征的患者。因此,微量白蛋白尿的评估可能有助于原发性高血压风险的分层。